Results 211 to 220 of about 8,718,410 (331)
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Cisplatin-mediated activation of NF-κB promotes lung cancer stem cell formation via DNA repair pathways. [PDF]
Zhang L +7 more
europepmc +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Nanogold-Lateral Flow Assay for Ginseng DNA Differentiation. [PDF]
Tiffere AH, Sojoudi P, Oberc C, Li PCH.
europepmc +1 more source
Loop-mediated isothermal amplification of DNA.
T. Notomi +6 more
semanticscholar +1 more source
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
The Latest Practices in Culture-Free Detection of Bacteria in Water, From Sampling to Membrane Filtration and DNA Extraction: A Systematic Review. [PDF]
Togănel RO +7 more
europepmc +1 more source

